Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 100 Total
DXR - Daxor Corp. - Stock Price Chart
TickerDXR [NASD]
CompanyDaxor Corp.
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap37.13MEPS (ttm)1.04
P/E7.58EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.24EPS Q/Q-51.69%
Dividend-Sales Q/Q-5925.72%
Insider Own57.67%Inst Own1.34%
Insider Trans0.12%Inst Trans-
Short Float0.55%Earnings-
Analyst Recom1.00Target Price23.00
Avg Volume2.25K52W Range7.11 - 13.13
Nov-13-23 08:00AM New Randomized Controlled Trial Demonstrates the Efficacy of Daxor's BVA Guided-Care in Heart Failure Patients (GlobeNewswire) +7.05%
Nov-09-23 08:00AM Daxor Corporation Awarded New Patent for Remote Monitoring of Blood Volume (GlobeNewswire)
Oct-13-23 08:00AM Expert Panelists Advocate Use of Daxor's Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting (GlobeNewswire)
Oct-11-23 08:00AM New Data from Banner University Medicine Demonstrating Effectiveness of BVA-100 Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific Meeting (GlobeNewswire)
Oct-04-23 08:00AM Daxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services Program (GlobeNewswire)
Sep-27-23 08:00AM Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023 (GlobeNewswire)
Sep-26-23 08:00AM DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL23 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXORS BLOOD VOLUME DIAGNOSTIC (BVA-100®) (GlobeNewswire)
Sep-11-23 12:00PM Daxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patients (GlobeNewswire)
Sep-07-23 09:15AM Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-28-23 04:15PM Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders (GlobeNewswire)
Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage and andrology services, such as semen analysis, sperm washing, and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in Oak Ridge, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Feldschuh Michael RichardChief Executive OfficerDec 01Buy7.808006,240162,492Dec 01 08:58 PM
Michel Robert JChief Financial OfficerDec 01Buy7.751801,39510,430Dec 01 09:00 PM
Michel Robert JChief Financial OfficerNov 24Buy7.945003,97010,250Nov 27 06:03 AM
Feldschuh Michael RichardCHIEF EXECUTIVE OFFICERNov 10Buy7.831,0017,838161,608Nov 13 06:33 AM
Feldschuh Michael RichardCHIEF EXECUTIVE OFFICERNov 09Buy7.854013,148160,607Nov 13 06:33 AM
ARQT - Arcutis Biotherapeutics Inc - Stock Price Chart
TickerARQT [NASD, RUT]
CompanyArcutis Biotherapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap187.82MEPS (ttm)-5.65
P/E-EPS this Y34.35%
Forward P/E-EPS next Y27.76%
PEG-EPS past 5Y-110.36%
P/S50.90EPS next 5Y9.80%
P/B2.63EPS Q/Q44.68%
Dividend-Sales Q/Q-
Insider Own18.13%Inst Own70.24%
Insider Trans0.46%Inst Trans13.36%
Short Float22.67%EarningsNov 03/b
Analyst Recom1.86Target Price15.86
Avg Volume2.39M52W Range1.77 - 18.04
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watanabe Todd FranklinSee RemarksDec 01Option Exercise1.6859,525100,038513,682Dec 01 08:51 PM
Matsuda MasaruSee RemarkNov 21Sale1.981,8503,66146,634Nov 21 05:47 PM
Frazier Life Sciences VIII, L.10% OwnerOct 24Buy2.5080,000200,0008,764,232Oct 26 04:09 PM
Burnett PatrickSee RemarksAug 21Sale7.041,60511,30258,357Aug 22 12:24 PM
Watanabe Todd FranklinSee RemarksMay 31Buy6.381,4639,334515,145Dec 01 08:51 PM
CVV - CVD Equipment Corp. - Stock Price Chart
TickerCVV [NASD]
CompanyCVD Equipment Corp.
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap34.37MEPS (ttm)-0.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.26EPS next 5Y-
P/B1.19EPS Q/Q-1270.21%
Dividend-Sales Q/Q-23.21%
Insider Own18.54%Inst Own27.84%
Insider Trans29.62%Inst Trans-0.75%
Short Float0.60%EarningsNov 14/a
Analyst Recom1.00Target Price16.00
Avg Volume15.73K52W Range3.93 - 15.82
CVD Equipment Corp. engages in the design, development, and manufacture of chemical vapor deposition, gas control, and other state-of-the-art equipment and process solutions. It operates through the following segments: Chemical Vapor Deposition (CVD), Stainless Design Concepts (SDC), CVD Materials, and Corporate. The Chemical Vapor Deposition segment is utilized for chemical Vapor deposition equipment manufacturing. The Stainless Design Concepts segment includes ultra-high purity manufacturing division in Saugerties, New York for gas control systems. The CVD Materials segment offers material coatings for aerospace, medical, electronic, and other application. The Corporate segment refers to the firm's administration activities. Its services include anti-corrosion, application lab, collaboration, customer support, printed electronics, fabricated quartzware, and process software. The firm serves the aerospace, glass coatings, medical, military, nanomaterials, optoelectronics, semiconductor, and solar photovoltaics markets. The company was founded by Leonard A. Rosenbaum on October 13, 1982 and is headquartered in Central Islip, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AFRICK ANDREW10% OwnerDec 01Buy4.7853,551255,9741,076,834Dec 01 08:26 PM
AFRICK ANDREW10% OwnerNov 30Buy4.5142,659192,3921,023,283Dec 01 08:26 PM
AFRICK ANDREW10% OwnerNov 16Buy5.6162,000347,820980,624Nov 17 01:59 PM
AFRICK ANDREW10% OwnerNov 15Buy5.5185,837472,962918,624Nov 17 01:59 PM
AFRICK ANDREW10% OwnerAug 22Buy7.0012,19585,365832,787Aug 23 04:00 PM
SGHT - Sight Sciences Inc - Stock Price Chart
TickerSGHT [NASD, RUT]
CompanySight Sciences Inc
CountryUSA
IndustryMedical Devices
Market Cap141.38MEPS (ttm)-1.28
P/E-EPS this Y30.55%
Forward P/E-EPS next Y8.20%
PEG-EPS past 5Y-55.84%
P/S1.71EPS next 5Y-
P/B1.10EPS Q/Q42.28%
Dividend-Sales Q/Q7.13%
Insider Own42.92%Inst Own36.96%
Insider Trans4.94%Inst Trans-2.95%
Short Float3.59%EarningsNov 07/a
Analyst Recom2.67Target Price2.58
Avg Volume480.65K52W Range1.04 - 15.30
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Encrantz StaffanDirectorNov 30Buy3.46140,777486,6381,012,150Dec 01 07:39 PM
Encrantz StaffanDirectorNov 29Buy3.503,22311,280871,373Dec 01 07:39 PM
Encrantz StaffanDirectorNov 28Buy3.46253,669877,137868,150Nov 28 08:32 PM
Encrantz StaffanDirectorNov 27Buy3.31246,331815,947614,481Nov 28 08:32 PM
Badawi DavidChief Technology OfficerNov 24Option Exercise0.11150,00016,5001,631,196Nov 28 08:16 PM
PLSE - Pulse Biosciences Inc - Stock Price Chart
TickerPLSE [NASD, RUT]
CompanyPulse Biosciences Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap503.80MEPS (ttm)-0.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.07%
P/S-EPS next 5Y-
P/B9.66EPS Q/Q60.37%
Dividend-Sales Q/Q-
Insider Own68.79%Inst Own7.07%
Insider Trans1.03%Inst Trans-15.53%
Short Float13.70%EarningsNov 13/b
Analyst Recom3.00Target Price5.00
Avg Volume168.28K52W Range1.85 - 10.21
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DUGGAN ROBERT WDirectorNov 29Option Exercise5.951,6679,91936,392,861Dec 01 07:36 PM
DUGGAN ROBERT WDirectorNov 29Buy9.44158,6001,497,18436,551,461Dec 01 07:36 PM
DUGGAN ROBERT WDirectorNov 29Buy9.2160,000552,60060,000Dec 01 07:36 PM
DUGGAN ROBERT WDirectorNov 28Buy8.98124,3971,117,08536,391,194Nov 30 07:25 PM
DUGGAN ROBERT WDirectorNov 17Buy6.1020,241123,47036,266,797Nov 20 08:56 PM
VTN - Invesco Trust for Investment Grade New York Municipals - Stock Price Chart
TickerVTN [NYSE]
CompanyInvesco Trust for Investment Grade New York Municipals
CountryUSA
IndustryClosed-End Fund - Debt
Market Cap476.80MEPS (ttm)0.16
P/E63.31EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S31.40EPS next 5Y-
P/B0.87EPS Q/Q-
Dividend4.34%Sales Q/Q5.10%
Insider Own-Inst Own25.79%
Insider Trans-Inst Trans-
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume85.56K52W Range8.49 - 10.95
Invesco Trust for Investment Grade New York Municipals is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Canada Ltd., Invesco Hong Kong Limited, and INVESCO Senior Secured Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade New York municipal securities which include municipal bonds, municipal notes, municipal commercial paper, and lease obligations. It employs fundamental analysis with bottom-up security selection approach to create its portfolio. The fund was formerly known as Invesco Van Kampen Trust for Investment Grade New York Municipals. Invesco Trust for Investment Grade New York Municipals was formed on March 27, 1992 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerNov 30Buy9.9883,498833,3102,479,585Dec 01 06:38 PM
Saba Capital Management, L.P.10% OwnerNov 29Buy9.985004,9902,396,087Dec 01 06:38 PM
Saba Capital Management, L.P.10% OwnerNov 28Buy9.8945,026445,3072,395,587Nov 28 06:13 PM
Saba Capital Management, L.P.10% OwnerNov 22Buy9.848,32581,9182,350,561Nov 24 06:35 PM
Saba Capital Management, L.P.10% OwnerNov 21Buy9.783,60035,2082,342,236Nov 21 05:58 PM
VPV - Invesco Pennsylvania Value Municipal Income Trust - Stock Price Chart
TickerVPV [NYSE]
CompanyInvesco Pennsylvania Value Municipal Income Trust
CountryUSA
IndustryClosed-End Fund - Debt
Market Cap234.01MEPS (ttm)-0.19
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S12.71EPS next 5Y-
P/B0.87EPS Q/Q-
Dividend4.27%Sales Q/Q3.60%
Insider Own-Inst Own18.88%
Insider Trans-Inst Trans-
Short Float0.15%Earnings-
Analyst Recom-Target Price-
Avg Volume58.20K52W Range8.58 - 10.58
Dec-01-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
Nov-01-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
Oct-02-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
Sep-01-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
Aug-01-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
Jul-03-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
Jun-08-23 09:15AM Invesco Advisers Announces Portfolio Management Changes for Invesco Municipal Closed-End Funds (PR Newswire)
Jun-01-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
May-01-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
Apr-03-23 12:15PM Invesco Closed-End Funds Declare Dividends (PR Newswire)
Invesco Pennsylvania Value Municipal Income Trust is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Canada Ltd., Invesco Hong Kong Limited, and INVESCO Senior Secured Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade Pennsylvania municipal securities which include municipal bonds, municipal notes, municipal commercial paper, and lease obligations. It employs fundamental analysis with bottom-up security selection approach to create its portfolio. The fund was formerly known as Invesco Van Kampen Pennsylvania Value Municipal Income Trust. Invesco Pennsylvania Value Municipal Income Trust was formed on April 30, 1993 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerNov 30Buy9.632,39723,0832,507,203Dec 01 06:36 PM
Saba Capital Management, L.P.10% OwnerNov 28Buy9.4874,537706,6112,504,806Nov 28 06:12 PM
Saba Capital Management, L.P.10% OwnerNov 27Buy9.4922,064209,3872,430,269Nov 28 06:12 PM
NXJ - Nuveen New Jersey Quality Municipal Income Fund - Stock Price Chart
TickerNXJ [NYSE]
CompanyNuveen New Jersey Quality Municipal Income Fund
CountryUSA
IndustryClosed-End Fund - Debt
Market Cap477.02MEPS (ttm)-1.57
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S13.21EPS next 5Y-
P/B0.87EPS Q/Q-
Dividend3.35%Sales Q/Q-3.10%
Insider Own-Inst Own19.75%
Insider Trans-Inst Trans-
Short Float0.11%Earnings-
Analyst Recom-Target Price-
Avg Volume104.35K52W Range10.06 - 12.20
Nuveen New Jersey Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New Jersey. The fund invests in undervalued municipal securities and other related investments that are, exempt from regular federal and New Jersey income taxes that are rated Baa or BBB or better. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) New Jersey Municipal Bond Index. The fund was formerly known as Nuveen New Jersey Dividend Advantage Municipal Fund. Nuveen New Jersey Quality Municipal Income Fund was formed on June 1, 1999 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerNov 30Buy11.5146,424534,3405,261,856Dec 01 06:35 PM
Saba Capital Management, L.P.10% OwnerNov 29Buy11.4840,888469,3945,215,432Dec 01 06:35 PM
Saba Capital Management, L.P.10% OwnerNov 28Buy11.38111,5401,269,3255,174,544Nov 28 06:10 PM
Saba Capital Management, L.P.10% OwnerNov 27Buy11.3211,779133,3385,063,004Nov 28 06:10 PM
Saba Capital Management, L.P.10% OwnerNov 21Buy11.19101,9561,140,8885,051,225Nov 21 05:56 PM
NQP - Nuveen Pennsylvania Quality Municipal Income Fund - Stock Price Chart
TickerNQP [NYSE]
CompanyNuveen Pennsylvania Quality Municipal Income Fund
CountryUSA
IndustryClosed-End Fund - Debt
Market Cap415.03MEPS (ttm)-1.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S13.51EPS next 5Y-
P/B0.85EPS Q/Q-
Dividend3.22%Sales Q/Q1.20%
Insider Own-Inst Own22.99%
Insider Trans-Inst Trans-
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume73.83K52W Range9.65 - 12.01
Nuveen Pennsylvania Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of Pennsylvania. The fund invests in tax exempt municipal bonds, with a rating of Baa/BBB or higher. It employs fundamental analysis, with bottom-up stock picking approach, to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's Pennsylvania Municipal Bond Index and Standard & Poor's National Municipal Bond Index. The fund was formerly known a Nuveen Pennsylvania Investment Quality Municipal Fund. Nuveen Pennsylvania Quality Municipal Income Fund was formed on December 20, 1990 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerNov 29Buy10.9828,424312,0964,304,522Dec 01 06:33 PM
Saba Capital Management, L.P.10% OwnerNov 28Buy10.9350,625553,3314,276,098Nov 28 06:08 PM
Saba Capital Management, L.P.10% OwnerNov 27Buy10.8933,162361,1344,225,473Nov 28 06:08 PM
Saba Capital Management, L.P.10% OwnerNov 21Buy10.806,52070,4164,192,311Nov 21 05:51 PM
Saba Capital Management, L.P.10% OwnerNov 20Buy10.7210,287110,2774,185,791Nov 21 05:51 PM
NMAI - Nuveen Multi-Asset Income Fund - Stock Price Chart
TickerNMAI [NYSE]
CompanyNuveen Multi-Asset Income Fund
CountryUSA
IndustryClosed-End Fund - Equity
Market Cap396.76MEPS (ttm)0.64
P/E18.55EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend10.53%Sales Q/Q-
Insider Own-Inst Own26.80%
Insider Trans-Inst Trans-
Short Float0.18%Earnings-
Analyst Recom-Target Price-
Avg Volume76.31K52W Range10.60 - 13.02
The Fund's investment objective is to provide attractive total return through high current income and capital appreciation. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment strategy uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit. The relative allocations of the Fund's managed assets for investment between equity and debt securities, and relative allocations to the different types of equity and income strategies, will vary from time to time, consistent with the Fund's investment objective. The Fund uses leverage.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerNov 30Buy11.651,65119,2344,717,729Dec 01 06:31 PM
Saba Capital Management, L.P.10% OwnerNov 29Buy11.687,60788,8504,716,078Dec 01 06:31 PM
Saba Capital Management, L.P.10% OwnerNov 27Buy11.5313,150151,6204,708,471Nov 28 06:06 PM
Saba Capital Management, L.P.10% OwnerNov 24Buy11.526006,9124,695,321Nov 24 06:33 PM
Saba Capital Management, L.P.10% OwnerNov 22Buy11.595,21660,4534,694,721Nov 24 06:33 PM
12345678910